Eltrombopag Side Effects

Some side effects of eltrombopag may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

For the Consumer

Applies to eltrombopag: oral tablet

Get emergency medical help if you have any of these signs of an allergic reaction while taking eltrombopag: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using eltrombopag and call your doctor at once if you have:

• pain or burning when you urinate;

• fever, chills, body aches, flu symptoms, unusual weakness or tired feeling;

• nausea, upper stomach pain, itching, loss of appetite;

• dark urine, clay-colored stools;

• jaundice (yellowing of the skin or eyes);

• pain, swelling, warmth, or redness in one or both legs;

• easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin; or

• blurred vision, eye pain, or seeing halos around lights.

Common side effects may include:

• diarrhea, vomiting, upset stomach;

• cold symptoms such as stuffy nose, sneezing, cough, sore throat;

• headache, muscle pain, back pain, swelling in your hands or feet;

• tingly feeling;

• mild itching or rash;

• sleep problems (insomnia); or

• temporary hair loss.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For Healthcare Professionals

Applies to eltrombopag: oral tablet

Hematologic

In clinical studies, hemorrhage was the most common serious adverse reaction and most hemorrhagic reactions followed discontinuation of eltrombopag.

Hematologic side effects have included hemorrhage and thrombocytopenia (2%).

Gastrointestinal

Gastrointestinal side effects have included nausea (6%), vomiting (4%), and dyspepsia (2%).

Other

Other side effects have included menorrhagia (4%), paresthesia (3%), and ecchymosis (2%).

Musculoskeletal

Musculoskeletal side effects have included myalgia (3%).

Ocular

Ocular side effects have included cataracts (3%) and conjunctival hemorrhage (2%).

Hepatic

Hepatic side effects have included increased ALT (2%) and increased AST (2%).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.